Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/34210327http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34210327http://www.w3.org/2000/01/rdf-schema#comment"

Background

Metastasis is a major challenge in cervical cancer treatment. Previous studies have shown that the dual functional protein apurinic/apyrimidinic endonuclease 1 (APE1) promotes tumor metastasis and is overexpressed in cervical cancer. However, the biological role and mechanism of APE1 in cervical cancer metastasis have rarely been studied.

Methods

We used gene set enrichment analysis (GSEA) to determine the APE1-related signaling pathways in cervical cancer. To investigate the role and mechanism of APE1 in cervical cancer metastasis and invasion, immunohistochemistry, immunofluorescence, western blotting, secondary structure prediction, coimmunoprecipitation, luciferase reporter, and electrophoretic mobility shift assays were performed. The inhibitory effects of the APE1 redox function inhibitor APX3330 on cervical cancer metastasis were evaluated using animal models.

Results

Clinical data showed that high expression of APE1 was associated with lymph node metastasis in cervical cancer patients. GSEA results showed that APE1 was associated with epithelial to mesenchymal transition (EMT) in cervical cancer. Ectopic expression of APE1 promoted EMT and invasion of cervical cancer cells, whereas inhibition of APE1 suppressed EMT and invasion of cervical cancer cells in a redox function-dependent manner. Notably, APE1 redox function inhibitor APX3330 treatment dramatically suppressed cervical cancer cell lymph node and distant metastasis in vivo. Furthermore, we found that APE1 enhanced the interaction between ZEB1 and the E-cadherin promoter by binding to ZEB1, thereby suppressing the expression of E-cadherin, a negative regulator of EMT.

Conclusion

Our findings help to elucidate the role played by APE1 in cervical cancer metastasis and targeting APE1 redox function may be a novel strategy for inhibiting cervical cancer metastasis."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.org/dc/terms/identifier"doi:10.1186/s13046-021-02006-5"xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Li Q."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Wang D."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Song G."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Wang J.M."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Duan W."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Xu C.X."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Wang S.N."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Mao C.Y."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Westover K.D."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Zhou Z.W."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Qian C.Y."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Zi D."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/author"Deng M.S."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/name"J Exp Clin Cancer Res"xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/pages"220"xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/title"Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT."xsd:string
http://purl.uniprot.org/citations/34210327http://purl.uniprot.org/core/volume"40"xsd:string
http://purl.uniprot.org/citations/34210327http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/34210327
http://purl.uniprot.org/citations/34210327http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/34210327
http://purl.uniprot.org/uniprot/#_A0A0C4DGK8-mappedCitation-34210327http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34210327
http://purl.uniprot.org/uniprot/#_A0A0E3XJU3-mappedCitation-34210327http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34210327
▶